KRAS and pancreatic neoplasm: Artesunate (ART), an anti-malarial, induces an iron- and ROS-dependent cell killing in pancreatic ductal adenocarcinoma cell lines with wild-type and mutant K-Ras, which indicates ART can function as a specific inducer of ferroptosis in pancreatic cancer cells (Eling et al., 2015).